Clinical and pharmacological hallmarks of rifapentine’s use in diabetes patients with active and latent tuberculosis: do we know enough?

• Main Authors: Zheng C (Author), Hu X (Author), Zhao L (Author), Hu M (Author), Gao F (Author)
• Formato: Livro
• Publicado em: Dove Medical Press, 2017-10-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Chunlan Zheng,1,* Xiufen Hu,2,* Li Zhao,1 Minhui Hu,1 Feng Gao3 1Department of Internal Medicine – Section 5, Wuhan Pulmonary Hospital (Wuhan Tuberculosis Control Institute), 2Department of Paediatrics, Tongji Hospital, 3Department of Endocrinology, Union Hospital, Tongji Medical College,...